Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia

Lasers in Surgery and Medicine

Volumn 31, Issue 3, 2002, Pages 158-163

  Chen, Bin ^a   Roskams, Tania ^b   De Witte, Peter A M ^a  

^a Faculteit Farmaceutische Wetenschappen   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Apoptosis; Direct cytotoxicity; Hypericin; Hyperthermia; Photodynamic therapy; Vascular effect

Indexed keywords

ANTINEOPLASTIC AGENT; HOE 33342; HYPERICIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLOOD VESSEL; BLOOD VESSEL INJURY; CANCER SURVIVAL; CELL DAMAGE; CELL DEATH; CELL KILLING; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HYPERTHERMIA; HYPERTHERMIC THERAPY; MOUSE; NICK END LABELING; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; STAINING; TREATMENT PLANNING; TUMOR CELL; VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZIMIDAZOLES; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; FEMALE; HYPERTHERMIA, INDUCED; IN SITU NICK-END LABELING; MICE; MICE, INBRED C3H; NEOPLASMS, EXPERIMENTAL; PERYLENE; PHOTOCHEMOTHERAPY; STAINING AND LABELING; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0036381234     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/lsm.10089     Document Type: Article

References (22)

1. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Photodynamic therapy. J Natl Cancer Inst 1998;90:889-905.
2. Sharman WM, Allen CM, van Lier JE. Photodynamic therapeutics: Basic principles and clinical applications. Drug Discov Today 1999;4:507-517.
3. Lavie G, Mazur Y, Lavie D, Meruelo D. The chemical and biological properties of hypericin-A compound with a broad spectrum of biological activities. Med Res Rev 1995;15:111-119.
4. Chen B, Zupko I, de Witte PA. Photodynamic therapy with hypericin in a mouse P388 tumor model. Int J Oncol 2001;18: 737-742.
5. Chen B, Xu Y, Roskams T, Delaey E, Agostinis P, Vandenheede JR, de witte P. Efficacy of antitumoral photodynamic therapy with hypericin: Relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model. Int J Cancer 2001;93:275-282.
6. Chen B, Roskams T, Xu Y, Agostinis P, de Witte P. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model. Int J Cancer 2002;98:284-290.
7. Chen B, Xu Y, Agostinis P, de Witte PA. Synergistic effect of photodynamic therapy with hypericin in combination with hyperthermia on loss of clonogenicity of RIF-1 cells. Int J Oncol 2001;18:1279-1285.
8. Vandenbogaerde AL, Delaey EM, Vantieghem AM, Himpens BE, Merlevede WJ, de Witte PA. Cytotoxicity and antiproliferative effect of hypericin and derivatives after photosensitization. Photochem Photobiol 1998;67:119-125.
9. Twentyman PR, Brown JM, Gray JW, Franko AJ, Scoles MA, Kallman RF. A new mouse tumor model system (RIF-1) for comparison of end-point studies. J Natl Cancer Inst 1980;64: 595-604.
10. van Geel IP, Oppelaar H, Oussoren YG, Schuitmaker JJ, Stewart FA. Mechanisms for optimising photodynamic therapy: Second-generation photosensitisers in combination with mitomycin C. Br J Cancer 1995;72:344-350.
11. Slim BG, Laux WT, Rutland MD, Palmer BN, Wilson WR. Scintigraphic imaging of the hypoxia marker (99 m) technetium-labeled (2,2′-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (99 mTc-labeled HL-91; prognox): Noninvasive detection of tumor response to the antivascular agent 5, 6-dimethylxanthenone-4-acetic acid. Cancer Res 2000;60: 4582-4588.
12. Henderson BW, Waldow SM, Mang TS, Potter WR, Malone PB, Dougherty TJ. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res 1985;45:572-576.
13. Glassberg E, Lewandowski L, Halcin C, Lask G, Uitto J. Hyperthermia potentiates the effects of aluminum phthalocyanine tetrasulfonate-mediated photodynamic toxicity in human malignant and normal cell lines. Lasers Surg Med 1991;11:432-439.
14. Henderson BW, Waldow SM, Potter WR, Dougherty TJ. Interaction of photodynamic therapy and hyperthermia: Tumor response and cell survival studies after treatment of mice in vivo. Cancer Res 1985;45:6071-6077.
15. Rasch MH, Tijssen K, VanSteveninck J, Dubbelman TMAR. Synergistic interaction of photodynamic treatment with the sensitizer aluminum phthalocyanine and hyperthermia on loss of clonogenicity of CHO cells. Photochem Photobiol 1996; 64:586-593.
16. Mang TS, Dougherty TJ. Time and sequence dependent influence of in vitro photodynamic therapy (PDT) survival by hyperthermia. Photochem Photobiol 1985;42:533-540.
17. Prinsze C, Dubbelman TMAR, VanSteveninck J. Potentiation of the thermal inactivation of glyceraldehyde-3-phosphate dehydrogenase by photodynamic therapy-A possible model for the synergistic interaction between photodynamic therapy and hyperthermia. Biochem J 1991;276:357-362.
18. Kimel S, Svaasand LO, Hammer-Wilson M, Gottfried V, Cheng S, Svaasand E, Berns MW. Demonstration of synergistic effects of hyperthermia and photodynamic therapy using the chick chorioallantoic membrane model. Lasers Surg Med 1992;12:432-440.
19. Liu DL, Andersson-Engels S, Sturesson C, Svanberg K, Hakansson CH, Svanberg S. Tumour vessel damage resulting from laser-induced hyperthermia alone and in combination with photodynamic therapy. Cancer Lett 1997;111:157-165.
20. Uehara M, Inokuchi T, Sano K, Pe MB. The anti-tumor effect of photodynamic therapy evaluated by bromodeoxyuridine immunohistochemistry. Int J Oral Maxillofac Surg 1998;27: 204-208.
21. Song CW. Effect of local hyperthermia on blood flow and microenvironment: A review. Cancer Res 1984;44:4721s-4730s.
22. Pedley RB, Hill SA, Boxer GM, Flynn AA, Boden R, Watson R, Dearling J, Chaplin DJ, Begent RH. Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4,3-O-phosphate. Cancer Res 2001;61:4716-4722.